This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Mylan, Inc.
Mylan, Inc., a global leader in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1961, Mylan has established itself as a key player in generic and specialty medications, focusing on providing high-quality, affordable healthcare solutions. The company is renowned for its extensive portfolio, which includes a wide range of generic and branded drugs, biosimilars, and over-the-counter products. Mylan's commitment to innovation and accessibility sets it apart in the competitive landscape, enabling it to serve millions of patients worldwide. With a strong market position, Mylan has achieved significant milestones, including strategic mergers and acquisitions that have expanded its global reach and product offerings. The company's dedication to improving health outcomes continues to drive its success in the ever-evolving pharmaceutical sector.
DitchCarbon Score
How does Mylan, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mylan, Inc.'s score of 45 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mylan, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of Viatris Inc., which may influence its climate commitments and emissions reporting. As part of its corporate family relationship with Viatris Inc., Mylan's climate initiatives and targets are likely aligned with those set by Viatris. However, no specific reduction targets or climate pledges have been documented for Mylan, indicating a potential area for development in their sustainability strategy. Given the lack of direct emissions data and reduction initiatives, Mylan, Inc. may benefit from adopting industry-standard climate commitments and setting measurable targets to enhance its environmental performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 302,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 354,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mylan, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
